Mediwound Stock News

Results Highlight the Safety and Efficacy in Hard-to-Heal Wounds

YAVNE, Israel, March 22, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective,

Primary Endpoint Met with Highly Statistically Significant ResultsFinal Data Readout Expected in Second Quarter of 2022

MediWound Ltd. (MDWD) CEO Sharon Malka on Q4 2021 Results - Earnings Call Transcript

MediWound (MDWD) delivered earnings and revenue surprises of 6.25% and 2.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus AbbVie's Rinvoq Gets Label Expansion To Treat Ulcerative Colitis AbbVie, Inc. (NYSE: ABBV) announced 

MediWound (NASDAQ: MDWD ) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings MediWound reported in-line EPS of $-0.15 versus an estimate of $-0.15. Revenue was … Full story available on Benzinga.com

MediWound press release (MDWD): Q4 GAAP EPS of -$0.15 in-line.Revenue of $5.49M (-18.1% Y/Y) misses by $0.05M.

Full-Year 2021 Total Revenues of $23.8 Million; Product Revenues Up 46%

Full-Year 2021 Total Revenues of $23.8 Million; Product Revenues Up 46%

MediWound (MDWD) delivered earnings and revenue surprises of 6.25% and 2.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ: TGA ) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ: IKNA ) is projected to report earnings for its fourth quarter. • RF Industries (NASDAQ: RFIL ) is likely to report quarterly earnings at $0.04 per share on revenue of $15.84 million. • Destination XL Group (NASDAQ: DXLG ) is estimated to report quarterly earnings at $0.13 per share on revenue of $131.88 million. • Liquidia (NASDAQ: LQDA ) is projected to report quarterly loss at $0.11 per share on revenue of $3.05 million. • IMV (NASDAQ: IMV ) is projected to report quarterly loss at $0.13 per share on revenue of $50.00 thousand. • Redhill Biopharma (NASDAQ: RDHL ) is likely to report quarterly loss at $0.33 per share on revenue of $24.08 million. • Designer Brands (NYSE: DBI ) is likely to report quarterly earnings at $0.16 per share on revenue of $839.61 million. • Kirkland''s (NASDAQ: KIRK ) is expected to report quarterly earnings at $0.

Catalyst (CPRX) delivered earnings and revenue surprises of -25% and 0.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

MediWound (NASDAQ:MDWD) is scheduled to announce Q4 earnings results on Thursday, March 17th, before market open.The consensus EPS Estimate is -$0.15 (-150.0% Y/Y) and the consensus…

Dipexium Pharmaceuticals, Inc. (PLXP) delivered earnings and revenue surprises of -5.80% and 17.51%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for